236 related articles for article (PubMed ID: 36915060)
1. Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema.
Koc H; Alpay A; Ugurbas SH
BMC Ophthalmol; 2023 Mar; 23(1):97. PubMed ID: 36915060
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
3. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
4. Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India.
Chakraborty D; Mondal S; Sengupta S; Maiti A; Boral S; Das A; Sinha TK; Nandi K
Indian J Ophthalmol; 2024 Jul; 72(7):1001-1006. PubMed ID: 38622856
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
Mishra SK; Sinha S; Chauhan R; Kumar A
Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Intravitreal Dexamethasone Implant and Posterior Subtenon Triamcinolone Injection in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes.
Gumus G; Erdogan G; Gunay BO; Karatas Durusoy G
Ophthalmologica; 2022; 245(5):439-445. PubMed ID: 35921811
[TBL] [Abstract][Full Text] [Related]
7. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
[No Abstract] [Full Text] [Related]
8. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
Arıkan Yorgun M; Toklu Y; Mutlu M
Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
[TBL] [Abstract][Full Text] [Related]
10. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
Ozsaygili C; Duru N
Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of intravitreal dexamethasone implant as a starting monotherapy and when switching from an anti-VEGF drug in diabetic macular edema].
Bikbov MM; Zainullin RM; Kudoyarova KI; Kalanov MR
Vestn Oftalmol; 2021; 137(6):5-11. PubMed ID: 34965061
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema.
Mahapatra SK; Parhi A; Shree P; Mohanty A
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S106-S110. PubMed ID: 38131551
[TBL] [Abstract][Full Text] [Related]
13. Early treatment with dexamethasone intravitreal implants in diabetic macular edema: Naïve versus refractory patients.
Bux AV; Fortunato F; Barone A; Russo V; Delle Noci N; Iaculli C
Eur J Ophthalmol; 2022 May; 32(3):1619-1626. PubMed ID: 34120496
[TBL] [Abstract][Full Text] [Related]
14. Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis.
Ji K; Zhang Q; Tian M; Xing Y
Medicine (Baltimore); 2019 May; 98(22):e15798. PubMed ID: 31145307
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
Kaldırım H; Savur F; Kırgız A; Atalay K
Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
He Y; Ren XJ; Hu BJ; Lam WC; Li XR
BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
Totan Y; Güler E; Gürağaç FB
Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal Dexamethasone in Diabetic Macular Oedema: A Way of Enhancing the Response to Anti-VEGF in Non- or Poor Responders?
Touhami S; Dupas B; Bertaud S; Tadayoni R; Couturier A
Ophthalmologica; 2022; 245(4):350-357. PubMed ID: 34587614
[TBL] [Abstract][Full Text] [Related]
19. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
[TBL] [Abstract][Full Text] [Related]
20. Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study.
Ruiz-Moreno JM; Ruiz-Medrano J
Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):941-949. PubMed ID: 36370170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
